Results 31 to 40 of about 312,508 (167)

Preference Testing in Medical Devices: Current Framework and Regulatory Gaps

open access: yesMedical Devices: Evidence and Research, 2022
Amy Lewis,1 Despoina Douka,1 Angeliki Koukoura,1 Vasiliki Valla,1 Amie Smirthwaite,2 Susanne Holm Faarbaek,3 Efstathios Vassiliadis1 1Evnia, Copenhagen, Denmark; 2RQM+, Nottingham, England; 3BK Medical, Herlev, DenmarkCorrespondence: Amy Lewis, Email ...
Lewis A   +6 more
doaj  

Tradeoffs and decision-making in moderate to severe psoriasis for oral versus injectable treatments: data from patients and dermatologists in Australia

open access: yesJournal of Dermatological Treatment
Background Oral systemic and injectable biologic treatments are available in Australia to treat moderate to severe psoriasis.Objective To examine how patients and dermatologists in Australia choose between oral and injectable treatments for psoriasis ...
Saxon D. Smith   +7 more
doaj   +1 more source

Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia

open access: yesBMC Cancer
Background Listening to patient voices is critical, in terms of how people experience their condition as well as their treatment preferences. This research explored the patient journey, therapy attributes and goals among treatment experienced adults with
Simon Fifer   +10 more
doaj   +1 more source

Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison

open access: yesBMC Medical Informatics and Decision Making, 2020
Background Incorporating patient preference (PP) information into decision-making has become increasingly important to many stakeholders. However, there is little guidance on which patient preference assessment methods, including preference exploration ...
Chiara Whichello   +6 more
doaj   +1 more source

Patient preferences for heart valve disease intervention

open access: yesHealth Expectations
Background This study aimed to determine how patients trade‐off the benefits and risks of two different types of procedures used to treat heart valve disease (HVD).
Simon Fifer   +4 more
doaj   +1 more source

Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor‐mutant non‐small cell lung cancer

open access: yesCancer Medicine
Introduction Evidence is limited on preferences of Japanese patients and physicians in treatment for epidermal growth factor receptor (EGFR)‐mutant non‐small cell lung cancer (NSCLC).
Akito Hata   +8 more
doaj   +1 more source

Patient Perception of Physician Attire Before and After Disclosure of the Risks of Microbial Contamination

open access: yesInternational Journal of Medical Students, 2013
Background: The white coat is traditionally considered to be the appropriate attire for physicians but it may also be contaminated with microbes and act as a potential source of infection.
Enoch C. T. So   +9 more
doaj   +1 more source

Incorporating patients in the development of clinical practice guidelines

open access: yesMedwave
Clinical practice guidelines are a set of recommendations developed systematically and based on the best available evidence. Their purpose is to enable healthcare providers and patients to make the best decisions regarding healthcare interventions ...
Germán Loyola   +4 more
doaj   +1 more source

Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives

open access: yesFrontiers in Psychology, 2023
BackgroundIn the treatment of Non-Small Cell Lung Cancer (NSCLC) the combination of Immuno- Oncotherapy (IO) and chemotherapy (CT) has been found to be superior to IO or CT alone for patients’ survival.
Serena Oliveri   +26 more
doaj   +1 more source

Multi-stakeholder use of patient experience data (PED): current state and future opportunities for the application of PED to inform decision-making

open access: yesJournal of Patient-Reported Outcomes
Patient experience data (PED) encompass information on patient’s experiences, disease impact, and treatment preferences. PED are critical inputs to the drug development process and help ensure medicines are developed with the interests of patients in ...
Chisom Kanu   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy